Products

Personalized Physiology Analytics Engine software
VGBio (DBA PhysIQ)
Drug Discovery & Research
PhysIQ offers an FDA-cleared AI-powered, cloud-based platform for personalized physiology analytics, utilizing wearable biosensor data to create individual baselines and detect subtle changes for proactive care and clinical trials.

See all 1 product →

About VGBio (DBA PhysIQ)

PhysIQ, operating under VGBio, is a leading healthcare AI company that has developed an advanced, personalized physiology data analytics platform. This platform is specifically designed to continuously track and integrate multiple vital signs from wearable biosensors. Unlike traditional methods that rely on population-based norms, PhysIQ’s technology establishes an individual patient’s unique physiological baseline and then utilizes artificial intelligence (AI) and deep neural network technology to detect subtle, yet clinically meaningful, deviations from that baseline. This capability provides physicians with unprecedented, highly personalized insights into a patient’s health status.

The company’s FDA-cleared analytics are leveraged across various applications in digital medicine. In healthcare delivery, the platform supports proactive care models such as remote patient monitoring and management for individuals with chronic conditions like heart failure, COPD, and cancer, as well as for post-acute care and Hospital-at-Home programs. For life sciences, PhysIQ’s solutions are critical for clinical trial support, enabling the collection and analysis of real-world data to accelerate drug development and validate product safety and efficacy.

PhysIQ’s technology acts as an early warning system, designed to identify potential health deteriorations often before a patient experiences noticeable symptoms, thereby enabling timely clinical intervention. It transforms continuous physiological data into actionable insights for health systems, payers, and pharmaceutical companies, ultimately aiming to improve patient outcomes and enhance the efficiency of care delivery.

Focus Areas

digital medicine personalized physiology analytics AI wearable biosensor data remote patient monitoring clinical trial support digital biomarkers proactive care disease exacerbation prediction heart failure COVID-19 oncology COPD

Business Intelligence

Key InvestorsLionBird, Purdue Foundry, 4490 Ventures, Global Health Sciences (GHS) Fund, Quark Venture Inc., GF Securities
PartnershipsOncoBay Clinical, InCarda Therapeutics, Syneos Health, Science 37, Janssen Pharmaceuticals (J&J), University of Illinois Hospital and Health Sciences System, Chicago Medical Society, U.S. Veteran's Affairs, US Department of Defense, Henry M. Jackson Foundation (HJF), Blue Cross and Blue Shield of Illinois (BCBSIL), Purdue University
AcquisitionsAcquired by Prolaio
TechnologyCloud-based platform, AI-powered algorithms, personalized dynamic baseline, device-agnostic, pinpointIQ® (patient care), accelerateIQ® (clinical trials), raw biosignal processing, deep neural networks
FDA Clearances7 cleared products (estimated)

What Physicians Need to Know

Digital Medicine & Personalized Physiology Analytics
VGBio (DBA PhysIQ) specializes in FDA-cleared Personalized Physiology Analytics technology, processing multiple vital signs from wearable biosensors to create a dynamic baseline for each individual. This allows for the detection of subtle deviations that may precede disease exacerbation or changes in health. [5, 7, 11, 16, 18]
AI & Wearable Biosensor Data
The company leverages advanced AI and deep learning algorithms to analyze continuous wearable biosensor data, including heart rate, respiratory rate, and activity, to generate personalized patient insights. [4, 7, 11, 16, 17, 18]
Remote Patient Monitoring (RPM) & Proactive Care
PhysIQ offers a unified platform for virtual care models such as post-acute remote patient monitoring and Hospital-at-Home programs. Their solution enables continuous monitoring, analysis, detection, and prediction of patient decompensation and complications, facilitating proactive care. [4, 5, 7, 18]
Clinical Trial Support
Through its VitaLink for Clinical Trials platform, PhysIQ provides a specialized patient monitoring solution that applies FDA-cleared machine learning analytics to sensor-derived physiological data. This supports clinical trials across diverse therapeutic areas, including cardiovascular health, pain, neurocognitive disease, and oncology, by transforming real-world data into insights for safety and efficacy validation. [9, 11, 17, 18]
Digital Biomarkers & Disease Exacerbation Prediction
PhysIQ develops novel, clinically-validated, FDA-approved digital biomarkers capable of predicting physiological changes from a personalized baseline, often significantly earlier than traditional standards of care. This includes the ability to predict heart failure hospitalization up to 10 days in advance and detect Atrial Fibrillation (AFib). [4, 7, 11, 18]
Therapeutic Areas
The company's solutions are applied across a range of serious diseases and conditions, including heart failure, COVID-19 (vaccine response), oncology, and COPD. [4, 7, 9, 11, 17, 18]
Physician Tip

Physicians can significantly benefit from VGBio (DBA PhysIQ)'s platform by gaining access to an early warning system that detects physiological decompensation days before traditional methods, enabling timely intervention and potentially preventing hospitalizations, readmissions, and ER visits. [4, 7, 11, 18] The platform provides highly personalized insights based on each patient's unique physiology, moving beyond generalized population data to offer actionable clinical intelligence. [4, 5, 7, 11, 16, 18] With multiple FDA 510(k) clearances for its AI-based analytics, PhysIQ offers a trusted and regulatory-compliant solution for enhancing virtual care models, including remote patient monitoring and Hospital-at-Home programs. [4, 5, 7, 9, 11, 16, 17, 18]

PhysIQ's cloud-based platform is designed to be device-agnostic, capable of collecting and processing data from any wearable biosensor. [9, 11, 17] This flexibility allows for integration with various existing and future wearable technologies, providing a comprehensive and adaptable monitoring solution.

Products by VGBio (DBA PhysIQ)

1 product in the directory

Personalized Physiology Analytics Engine software
VGBio (DBA PhysIQ)
Drug Discovery & Research
PhysIQ offers an FDA-cleared AI-powered, cloud-based platform for personalized physiology analytics, utilizing wearable biosensor data to create individual baselines and detect subtle changes for proactive care and clinical trials.

What the Web Says

VGBio (DBA PhysIQ) appears to encompass both a fitness brand (Physiq Fitness, Physiq Apparel) and a healthcare technology company (PhysIQ). Reviews for Physiq Fitness and Physiq Apparel are mixed, with some positive feedback on culture and product quality, but significant concerns regarding pay, billing practices, and management. PhysIQ, the healthcare technology company, has limited public reviews available, but those found suggest a driven, tech-focused environment.

Overall: Mixed

Strengths

  • Physiq Fitness offers a positive and energetic work environment with opportunities for personal and professional growth for some employees.
  • Physiq Fitness trainers are knowledgeable and tailor programs to individual goals.
  • Physiq Apparel products are described as comfortable, stretchy, and high-quality.
  • PhysIQ (healthcare tech) has a driven, tech-focused culture with friendly and helpful colleagues.
  • Physiq Body Treatments are non-invasive, comfortable, and require no downtime, with users reporting positive results for body contouring.
  • Physiq Body Treatments allow users to control the energy modulation for comfort.

Limitations

  • Inconsistency in scheduling and pay for Physiq Fitness employees.
  • Low pay and lack of benefits are common complaints among Physiq Fitness employees.
  • Billing problems, including double charging and difficulty with reconciliation, are frequently reported for Physiq Fitness.
  • Some Physiq Apparel leggings have a waistband seam that can be unflattering and a front middle seam that may cause camel toe.
  • Physiq Fitness management and job security receive lower ratings from employees.
  • Some Reddit users express frustration with Physiq Fitness's facility management and changes to class structures.

Based on reviews from: Indeed.com, Cartessa Aesthetics, YouTube, Nashville Wifestyles, Knoji.com, Capterra, Reddit

Last updated: 2026-07-19

Videos

News, demos, and interviews about VGBio (DBA PhysIQ).

Loading videos...

Videos load interactively. If none appear, search YouTube for VGBio (DBA PhysIQ) →

View all on YouTube

Press & Coverage

EINPresswire.com
Telemetrix and physIQ Unite to Create Advanced Integrated Patient Monitoring Solution
Telemetrix and physIQ have launched HealthTracer, LLC, a new company that will provide continuous remote patient monitoring services using the physIQ platform for high-acuity patients and advanced analytics. This collaboration aims to offer a streamlined care workflow integrated with leading EHR technology.
2023-09
Business Wire
physIQ Announces Two New Appointments to Executive Leadership Team to Advance Digital Health Market Commercialization
PhysIQ announced the appointment of John Wilson as Senior Vice President and General Manager of Life Sciences and Chris Englerth as Vice President of Marketing to accelerate the company's commercialization strategy and growth. These appointments are aimed at driving revenue growth and refining brand strategy in the healthcare and life sciences markets.
2022-05
BioSpace
PhysIQ Expands Clinical Leadership Team, Dr. Steve Steinhubl Joins as Chief Medical Officer
Dr. Steve Steinhubl, an expert in digital medicine, has joined physIQ as Chief Medical Officer to advance the adoption of the company's AI-based analytics for improved clinical outcomes and lower costs. He will help drive the deployment of physIQ's platform to health systems and provider groups worldwide.
2021-02
Medical Alley
PhysIQ Saw Significant Adoption of Their AI Technology in 2020
PhysIQ experienced significant adoption of its digital medicine platform in 2020, marked by breakthrough studies, partnerships, and an additional FDA clearance. The company's continuous remote patient monitoring system was utilized in COVID-19 studies and received a $6.6 million contract from the NIH to develop an AI-based COVID-19 digital biomarker.
2021-01
Business Wire
PhysIQ Recognized as a 2021 Hottest Health Tech Company
PhysIQ was named to the Observer's list of Hottest Health Tech Companies in Digital Health for the second consecutive year due to its technological advancements in continuous remote patient monitoring and its impact during the COVID-19 pandemic. The company's platform uses FDA-cleared AI-based analytics to transform biosensor data into personalized patient insights.
2021-01
MPO (Medical Product Outsourcing)
PhysIQ Expands Patent Portfolio for Artificial Intelligence Analytics in Wearables
PhysIQ received two new patent allowances from the U.S. Patent and Trademark Office for its core analytics in digital medicine, expanding its patent portfolio for AI analytics in wearables. These patents cover a deep net approach to estimating functional capacity from wearable sensor data and personalized physiology modeling technology.
2020-04
BioSpace
PhysIQ's Proprietary Personalized Analytics to be Used for COVID-19 Care with Newly Broadened FDA Labeling
PhysIQ announced FDA-sanctioned labeling for its pinpointIQu00ae continuous remote monitoring system, including its Multivariate Change Index (MCI), for use in the COVID-19 pandemic. This allows for continuous physiologic remote monitoring of homebound or quarantined patients with confirmed or suspected COVID-19.
2020-03
Purdue University News
Purdue-affiliated health technology company physIQ receives $500,000 to advance AI innovations
PhysIQ, a Purdue University-affiliated company, received a $500,000 investment from Purdue Research Foundation's Foundry Investment Fund to advance its medical technology. The company uses AI to improve healthcare delivery by applying it to real-time physiological data from wearable sensors.
2020-01

Frequently Asked Questions

VGBio (DBA PhysIQ) provides a personalized physiology analytics platform that leverages artificial intelligence (AI) and continuous data from wearable biosensors. This platform is designed to establish a unique baseline for each patient, detecting subtle physiological deviations that may indicate early health changes or disease exacerbation.
PhysIQ's technology supports proactive care and disease exacerbation prediction across various conditions, including heart failure, COVID-19, oncology, and COPD. Its FDA-cleared analytics can detect subtle changes in vital signs, offering early warnings of clinical deterioration for at-risk patients.
PhysIQ offers pinpointIQu00ae for continuous remote patient monitoring and accelerateIQu2122 for clinical trial support. Both platforms utilize FDA 510(k)-cleared analytics, ensuring regulatory compliance for generating clinical insights from wearable biosensor data.
PhysIQ ensures validity through its portfolio of FDA 510(k)-cleared analytics, which include algorithms for respiration rate, heart rate, atrial fibrillation detection, and personalized change detection. The platform processes continuous biosensor data to create dynamic baselines, enabling the detection of clinically meaningful changes.
PhysIQ has formed strategic partnerships, including a collaboration with Science 37 to enhance clinical trial data collection from connected devices and with Purdue University to develop smartwatch-based viral detection algorithms. Janssen Pharmaceuticals also utilizes PhysIQ's accelerateIQ for clinical studies.
VGBio (DBA PhysIQ) was recently acquired by Prolaio, which aims to enhance its next-generation connected heart care technology for both clinical care and research. This acquisition positions PhysIQ to further integrate its personalized physiology analytics into advanced healthcare solutions.
Specific pricing models for healthcare administrators and detailed support structures are not publicly available in the provided information. For comprehensive details on pricing, implementation support, and ongoing service, direct inquiry with VGBio (DBA PhysIQ) would be necessary.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.